Eltrombopag
Form: Oral Tablets & Oral Powder for Oral Suspension
Strength: Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet
Reference Brands: Promacta,Revolade
Category: Anemia
Eltrombopag is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and hepatitis C-associated thrombocytopenia. Marketed globally as Promacta (US) and Revolade (EU/Worldwide), it stimulates platelet production and reduces bleeding risk. Available in GMP-certified oral tablets and pediatric suspension, Eltrombopag is a high-demand product in hematology. Ideal for pharmaceutical wholesalers, importers, and B2B buyers seeking reliable sourcing of specialty medicines. We offer bulk supply, export support, and regulatory documentation. Partner with us for competitive pricing and global delivery of Eltrombopag. Contact us today to secure your supply of Eltrombopag for pharma B2B needs.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Deferoxamine
Strength: 500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details Get Enquiry
Deferasirox
Strength: 125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View Details Get Enquiry
Iron(III)-Isomaltoside Injection
Strength: 100mg/ml
Form: Injection
Reference Brands: Monofer,, Diafer, Monoferric
View Details Get Enquiry
Iron Dextran
Strength: 50 mg/mL
Form: injection
Reference Brands: Dexferrum,INFeD
View Details Get Enquiry